solifenacin succinate has been researched along with naftopidil in 2 studies
Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (naftopidil) | Trials (naftopidil) | Recent Studies (post-2010) (naftopidil) |
---|---|---|---|---|---|
522 | 194 | 343 | 233 | 58 | 124 |
Protein | Taxonomy | solifenacin succinate (IC50) | naftopidil (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0552 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.555 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.634 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, KC; Huo, LZ; Jing, HG; Luan, XH; Shi, BK; Wang, TC; Yuan, SX | 1 |
Ito, N; Kamiyama, Y; Kanamaru, S; Kawakita, M; Matsumoto, K; Muguruma, K; Shirahase, T; Takahashi, T; Tsukazaki, H; Tsunemori, H; Utsunomiya, N | 1 |
2 trial(s) available for solifenacin succinate and naftopidil
Article | Year |
---|---|
[A combination of solifenacin succinate and naftopidil in the treatment of female overactive bladder].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Young Adult | 2013 |
[A Crossover Comparison Study on Lower Urinary Tract Symptoms with Overactive Bladder Secondary to Benign Prostatic Hyperplasia: Naftopidil versus Tamsulosin with Solifenacin].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive | 2016 |